A detailed history of Virginia Retirement Systems Et Al transactions in Kiniksa Pharmaceuticals, Ltd. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 25,200 shares of KNSA stock, worth $536,256. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,200
Previous 32,300 21.98%
Holding current value
$536,256
Previous $454,000 3.74%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jan 02, 2024

SELL
$13.62 - $20.2 $96,702 - $143,420
-7,100 Reduced 21.98%
25,200 $437,000
Q2 2023

Aug 22, 2023

BUY
$10.44 - $16.48 $171,216 - $270,272
16,400 Added 103.14%
32,300 $454,000
Q1 2023

Jul 11, 2023

BUY
$10.7 - $15.79 $170,130 - $251,061
15,900 New
15,900 $171,000

Others Institutions Holding KNSA

About Kiniksa Pharmaceuticals, Ltd.


  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $734M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.